Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is AlphaMet's primary product?
- AlphaMet develops, manufactures, and markets the "CyclaPlex Correction System", an implant device for bunion surgery.
- What is the regulatory status of the CyclaPlex Correction System?
- The CyclaPlex Correction System is FDA cleared for use by surgeons.
- Who distributes AlphaMet's product in the U.S.?
- AlphaMet's CyclaPlex Correction System is distributed in the U.S. by Genesis Ortho Partners.
- When was AlphaMet founded?
- AlphaMet was founded in May 2012.
- What was AlphaMet's former name?
- AlphaMet was formerly known as Cycla Orthopedics and CyclaPlex.
- Where is AlphaMet headquartered?
- AlphaMet is headquartered in Bat Shlomo, Israel.
- How many employees does AlphaMet have?
- AlphaMet has 6 employees.
- What is AlphaMet's total funding to date?
- AlphaMet has raised a total of $820,000 through equity crowdfunding rounds, with PipelBiz as an investor. For full financing history, refer to startupim.
- When did AlphaMet complete its most recent funding round?
- AlphaMet completed a crowdfunding round in February 2020, raising $140,000.
- Who is a key founder of AlphaMet?
- Rafi Herzog is a founder of AlphaMet.